Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug safety
Manufacturing
Otsuka venture yanks sodium chloride for IV over labeling issue
Otsuka ICU Medical issued a voluntary recall of one lot of 0.9% sodium chloride injection for IV due to a possible mix-up of labels.
Joseph Keenan
Sep 24, 2026 9:41am
Daiichi unit recalls 3 epinephrine lots after complaints in US
Sep 4, 2026 11:12am
B. Braun launches IV solution recall over particle concerns
Aug 20, 2026 10:44am
EU regulators offer post-mortem of Tavneos withdrawal decision
Aug 14, 2026 11:04am
Neurocrine's Prader-Willi med tied to possible safety concerns
Aug 13, 2026 9:40am
Fresenius Kabi launches US recall of Actemra biosimilar
Aug 12, 2026 9:13am